Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -9.48%12.97K | -22.21%13.27K | -1.83%10.65K | 6.70%64.8K | 10.78%20.31K | -8.62%14.33K | 14.12%17.06K | 13.99%10.85K | -16.23%60.73K | 24.73%18.33K |
| Selling and administrative expenses | -19.90%5.47K | -39.64%5.77K | -5.94%3.15K | 13.23%34.8K | 18.24%12.81K | -16.52%6.83K | 28.33%9.56K | 65.97%3.35K | -27.68%30.73K | 50.49%10.83K |
| -General and administrative expense | -19.90%5.47K | -39.64%5.77K | -5.94%3.15K | 13.23%34.8K | 18.24%12.81K | -16.52%6.83K | 28.33%9.56K | 65.97%3.35K | -27.68%30.73K | 50.49%10.83K |
| Other operating expenses | 0.00%7.5K | 0.00%7.5K | 0.00%7.5K | 0.00%30K | 0.00%7.5K | 0.00%7.5K | 0.00%7.5K | 0.00%7.5K | 0.00%30K | 0.00%7.5K |
| Operating profit | 9.48%-12.97K | 22.21%-13.27K | 1.83%-10.65K | -6.70%-64.8K | -10.78%-20.31K | 8.62%-14.33K | -14.12%-17.06K | -13.99%-10.85K | 16.23%-60.73K | -24.73%-18.33K |
| Net non-operating interest income (expenses) | -436.36%-59 | -375.00%-57 | -300.00%-24 | -94.81%-150 | -1,916.67%-121 | 8.33%-11 | 79.31%-12 | -200.00%-6 | 12.50%-77 | 0.00%-6 |
| Non-operating interest expense | 436.36%59 | 375.00%57 | 300.00%24 | 94.81%150 | 1,916.67%121 | -8.33%11 | -79.31%12 | 200.00%6 | -12.50%77 | 0.00%6 |
| Other net income (expenses) | -16.67%-2.63K | -18.89%-10.7K | 0.00%-2.25K | 89.74%-9K | ||||||
| Other non-operating income (expenses) | ---- | ---- | -16.67%-2.63K | -18.89%-10.7K | ---- | ---- | ---- | 0.00%-2.25K | 0.00%-9K | ---- |
| Income before tax | 9.14%-13.03K | 21.93%-13.33K | -1.48%-13.3K | -8.37%-75.65K | -13.87%-31.13K | 8.62%-14.34K | -13.76%-17.07K | -11.35%-13.11K | 56.46%-69.81K | 73.31%-27.34K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 9.14%-13.03K | 21.93%-13.33K | -1.48%-13.3K | -8.37%-75.65K | -13.87%-31.13K | 8.62%-14.34K | -13.76%-17.07K | -11.35%-13.11K | 56.46%-69.81K | 73.31%-27.34K |
| Net income continuous operations | 9.14%-13.03K | 21.93%-13.33K | -1.48%-13.3K | -8.37%-75.65K | -13.87%-31.13K | 8.62%-14.34K | -13.76%-17.07K | -11.35%-13.11K | 56.46%-69.81K | 73.31%-27.34K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 9.14%-13.03K | 21.93%-13.33K | -1.48%-13.3K | -8.37%-75.65K | -13.87%-31.13K | 8.62%-14.34K | -13.76%-17.07K | -11.35%-13.11K | 56.46%-69.81K | 73.31%-27.34K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 9.14%-13.03K | 21.93%-13.33K | -1.48%-13.3K | -8.37%-75.65K | -13.87%-31.13K | 8.62%-14.34K | -13.76%-17.07K | -11.35%-13.11K | 56.46%-69.81K | 73.31%-27.34K |
| Diluted earnings per share | 0.00%-0.001 | 50.00%-0.001 | 0.00%-0.001 | 0.00%-0.01 | 0.00%-0.006 | 0.00%-0.001 | -100.00%-0.002 | 0.00%-0.001 | 50.00%-0.01 | 60.00%-0.006 |
| Basic earnings per share | 0.00%-0.001 | 50.00%-0.001 | 0.00%-0.001 | 0.00%-0.01 | 0.00%-0.006 | 0.00%-0.001 | -100.00%-0.002 | 0.00%-0.001 | 50.00%-0.01 | 60.00%-0.006 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.